RGBP (Regen BioPharma) 3-1 Month Momentum %: -85.71% (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Regen BioPharma 3-1 Month Momentum %?

Regen BioPharma RGBP 3-1 Month Momentum % is -85.71% as of Jul. 18, 2026. The stock has 7 warning signs investors should review. Among 1,389 Biotechnology companies, Regen BioPharma ranks worse than 98.63% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-18), Regen BioPharma's 3-1 Month Momentum % is -85.71%.

The industry rank for Regen BioPharma's 3-1 Month Momentum % or its related term are showing as below:

RGBP's 3-1 Month Momentum % is ranked worse than
98.63% of 1389 companies
in the Biotechnology industry
Industry Median: -13.25 vs RGBP: -85.71

Regen BioPharma  (OTCPK:RGBP) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Regen BioPharma 3-1 Month Momentum % Related Terms

RGBP vs SIGY, ENDV, CNBX: 3-1 Month Momentum % Comparison

For the Biotechnology subindustry, Regen BioPharma's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regen BioPharma 3-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regen BioPharma's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Regen BioPharma's 3-1 Month Momentum % falls into.


Regen BioPharma  (OTCPK:RGBP) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -85.71% mean?
Regen BioPharma (RGBP) has a 3-1 Month Momentum % of -85.71% as of Jul. 18, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Regen BioPharma and its competitors. According to the industry distribution chart, Regen BioPharma ranks #1370 out of 1389 companies in the Biotechnology industry, placing it in the top 98.6%.
Is Regen BioPharma's 3-1 Month Momentum % too high?
Regen BioPharma's current 3-1 Month Momentum % is -85.71%. Based on the distribution chart, Regen BioPharma ranks #1370 out of 1389 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Regen BioPharma's 3-1 Month Momentum % compare to SIGY and ENDV?
According to the Biotechnology industry distribution chart, Regen BioPharma ranks #1370 out of 1389 companies for 3-1 Month Momentum %. This places Regen BioPharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Regen BioPharma and its competitors. Regen BioPharma's current 3-1 Month Momentum % is -85.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regen BioPharma stock overvalued right now?
Based on GuruFocus' analysis, Regen BioPharma (RGBP) is currently considered Possible Value Trap. The stock's GF Value™ is $0.02, compared to a current price of $0.00 — trading 99.5% below its estimated fair value. The current 3-1 Month Momentum % is -85.71%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Regen BioPharma (RGBP), the current 3-1 Month Momentum % is -85.71% as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regen BioPharma Business Description

Other Exchanges RGBPP.PFD:USA
Address 8697 La Mesa Boulevard, Suite C, La Mesa, CA, USA, 91942
Regen BioPharma Inc is a USA-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II are cellular therapies designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.